Increased circulating levels of GDF15 have been reported in patients with breast, prostate, ovarian, and pancreatic cancers [94–98], including elevated serum levels of GDF15 reported in 6 of 10 (60%) metastatic breast carcinomas [98]. Here, GDF15 is linked to familial pancreatic carcinoma.